The Main Factor Risk on High Rate Death

For so many years, a lot of organization has been committed to providing cancer care in a community-based setting close to home. The all-encompassing oncology and hematology programs provide a complete range of diagnosis, cancer screening and treatment, also follow-up care for all types of cancer. Death rates on cancer have been decreasing since 1989, but approximately 40,920 women in the U.S. maybe expected to die in 2018 from breast cancer. An approximately 85% of breast cancers occur in women who have no family history of breast cancer at all. The two most common risk factors are gender and growing older. While you can’t change some breast cancer risk factors there are some risk factors that you can control like early cancer screening. Personal behaviors, such as diet and exercise, and taking medicines that contain hormones can impact the chances of getting breast cancer. Drinking alcohol have been clearly linked to an increased risk of breast cancer. Those risk increases depending with the amount of alcohol consumed. Being overweight or obese increases the risk in women after menopause. The experts recommend that you stay at a healthy weight throughout your life and avoid excess weight gain by balancing your food intake with physical activity.

Moderate and vigorous physical activity lowers risk for postmenopausal breast cancer. Vigorous physical activity lowers risk for pre-menopausal breast cancer, according to the recently released American Institute for Cancer Research Breast Cancer Report. Early detection of breast cancer is the leading factor in the historic decline in cancer deaths. With cancer screening mammography, treatment can be started earlier in the course of the disease, possibly before it has spread. Healthcare professionals treating older cancer patients often discover other health conditions that may limit the use of specific therapies. Unless there is sufficient evidence that older patients can benefit from standard dosage of some therapies, clinicians can be reluctant to give older patients potentially beneficial treatments. This practice of less intensive therapy in aging patients is historically understandable; however, a growing field of geriatric oncologists now consider chronological age insufficient evidence for denying aggressive cancer therapy. With cancer survival rates consistently increasing over the past decade, cancer is becoming a chronic illness for cancer patients. The ability to receive extended cancer therapy protocols at home and by mouth is beneficial in time, convenience and cost that accompanies typical IV administered treatments.

One of the main factors in the high rate of death due to lung cancer is that the disease is most often undetected until it has spread to other organs of the body. Lung cancer is the second most prevalent form of cancer in men and women and the top cancer killer among both sexes with proper cancer screening. In addition to the encouraging results from immunotherapy drugs, a newly discovered protein is showing promising results in detecting lung cancer earlier, providing new advanced treatment options to patients at the earliest stages of the disease. The stage of cancer will determine where the disease is located, if or where it has spread, what other parts of the body it may have affected, and the patient’s estimated survivable rate. The stage is the most credible indication of the cancer’s progression at a given period of time and is determined by patient procedures and tests such as physical examinations, cancer screening, imaging scans, biopsies, blood tests, surgery or other genetic testing.